Novo Nordisk’s diabetes medicine Rybelsus, an oral form of the GLP-1 drug semaglutide, provides similar cardiovascular ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

Merck & Co. has entered a competitive race for a new type of heart drug, announcing Tuesday it will pay China-based Jiangsu ...

AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes ...

Heart disease is the leading cause of death in the US, killing around 700,000 Americans each year. New research estimates that nearly 50,000 US lives could be saved annually with a one-two punch ...

Younger women who suffer a heart attack are three times more likely to die if they are taking an older brand of contraceptive pill. Those on second generation pills, such as Microgynon 30 and ...

The Pill carries very small risks of serious events, such as blood clots, heart attack, or stroke, which are outweighed by the excellent contraceptive and non-contraceptive benefits. Only 1/10,000 ...

Flecainide can be used with a “pill-in-the-pocket” approach. If documented to be successful and safe while hospitalized, flecainide can be used on an as-needed basis in the outpatient setting.